Ze‐Guang Han

14.8k citations
234 papers · 8.9k indexed · 1 hit paper · h-index 47
Topics
RNA modifications and cancer (24 papers)Epigenetics and DNA Methylation (24 papers)Cancer-related gene regulation (18 papers)

In The Last Decade

Ze‐Guang Han

219 papers receiving 8.7k citations

Hit Papers

Single-cell RNA-seq data analysis on the receptor ACE2 ex...2020202620222024202050010001.5k

Peers

Ze‐Guang Han
Comparison fields: 5 of 174
  • Molecular Biology 4.3k
  • Cancer Research 1.7k
  • Infectious Diseases 1.4k
  • Oncology 1.3k
  • Epidemiology 779
Replace Mauro Piacentini with:
Mauro Piacentini Italy
Yang Wang China
Yingyao Zhou United States
Jin Wang United States
Bing Sun China
Hua Liu China
Amy S. Lee United States
Qian Zhang China
William C. Aird United States
Wei Zhao China
Ze‐Guang Han relative to Mauro Piacentini Italy Mauro Piacentini's profile →
Citations per field
00.5×1.5×
Mauro Piacentini · 1×
Citations per year

Countries citing papers authored by Ze‐Guang Han

Since Specialization
Citations

This map shows the geographic impact of Ze‐Guang Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze‐Guang Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze‐Guang Han more than expected).

Fields of papers citing papers by Ze‐Guang Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze‐Guang Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze‐Guang Han. The network helps show where Ze‐Guang Han may publish in the future.

Co-authorship network of co-authors of Ze‐Guang Han

This figure shows the co-authorship network connecting the top 25 collaborators of Ze‐Guang Han. A scholar is included among the top collaborators of Ze‐Guang Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze‐Guang Han. Ze‐Guang Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 0
5 1
6 1
7 1
8 1
9 3
10 22
11 10
12 4
13 110
14 226
15 91
16 75
17 146
18 89
19 8
20 417

About Ze‐Guang Han

Ze‐Guang Han is a scholar working on Cancer Research, Parasitology and Molecular Biology, having authored 234 papers that have together received 8.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (24 papers), Epigenetics and DNA Methylation (24 papers) and Cancer-related gene regulation (18 papers). The work is most often cited by research in Cancer Research (1.7k citations), Infectious Diseases (1.4k citations) and Parasitology (461 citations). Ze‐Guang Han has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xin Zou, Jie Hao, Jiawei Zou, Ke Chen, Jian Huang, Zhiqin Wang, Xin Zhang, Jian Huang, Wei Hu and Qing Deng. Their work appears in journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026